Welcome to our dedicated page for Sensient Tech SEC filings (Ticker: SXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Sensient Technologies Corporation (NYSE: SXT), a global manufacturer and marketer of colors, flavors, and other specialty ingredients. Through these filings, investors can review the company’s official disclosures about its operations, financing arrangements, governance, and financial results.
Sensient’s SEC submissions include Form 8-K current reports that describe material events. Recent 8-K filings have covered topics such as quarterly earnings press releases and accompanying investor presentations, amendments to the company’s Amended and Restated By-Laws, leadership changes in the Color Group and Flavors & Extracts Group, and updates to credit facilities and receivables securitization programs. These documents offer timely insight into segment performance, capital structure, and corporate governance decisions.
In addition to current reports, investors typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed financial statements, segment information for the Flavors & Extracts, Color, and Asia Pacific groups, and discussions of risk factors and accounting policies. While those specific forms are not reproduced in the text above, they are part of Sensient’s regular reporting cycle and can be accessed through this filings feed.
Stock Titan enhances these regulatory documents with AI-powered summaries that highlight key points, such as changes in segment results, updates to credit agreements, or amendments to governance documents. Real-time integration with the SEC’s EDGAR system helps surface new filings as they become available, while structured views of items like 8-K exhibits and financing agreements make it easier to locate information on revolving credit facilities, receivables securitization programs, and related covenants.
For users interested in executive transitions, board actions, or committee changes, Item 5.02 and Item 5.03 disclosures in Sensient’s 8-K filings provide additional detail. For those focused on capital and liquidity, Items 1.01 and 2.03 filings describe material definitive agreements and direct financial obligations. By combining these documents with AI-generated explanations, this page helps investors interpret Sensient Technologies Corporation’s regulatory history and understand how specific filings relate to the SXT investment thesis.
Sensient Technologies senior vice president, general counsel and secretary John J. Manning reported equity compensation activity involving performance stock units and common shares on February 12, 2026. A block of 4,016 performance stock units vested at 85.4% of the target award and was converted into the same number of shares of common stock at $0 per share. To cover tax withholding related to this vesting, 2,008 common shares were disposed of at $97.93 per share, leaving him with 35,200.467 directly held common shares. He also has indirect beneficial ownership of additional common shares through his children, the company ESOP, and a supplemental benefit plan, and continues to hold several grants of performance stock units that may vest over future three‑year performance periods based on EBITDA growth, revenue and return on invested capital.
Sensient Technologies’ Chairman, President & CEO Paul Manning reported equity award activity on February 12, 2026. A block of 30,027 performance stock units vested at 85.4% of the target award and converted into an equal number of common shares at an exercise price of $0.
To cover tax withholding on this vesting, 15,013 common shares were withheld at $97.93 per share. After these transactions, Manning directly owned 275,954 common shares, plus indirect holdings of common stock through his children, the company’s ESOP, and a supplemental benefit plan.
He also continued to hold performance stock units that are eligible to vest after separate three-year performance periods, covering 42,442, 34,492, and 29,516 target shares. Vesting of these units depends on future achievement of performance criteria tied to adjusted EBITDA or revenue growth and return on invested capital.
Sensient Technologies’ VP and Chief Financial Officer, Tobin Tornehl, reported equity compensation activity involving performance stock units and common shares. On February 12, 2026, 1,502 performance stock units vested at 85.4% of the target award and converted into 1,502 shares of common stock at an exercise price of $0.
To cover taxes on this vesting, 751 common shares were withheld at $97.93 per share as a tax-withholding disposition, leaving 15,504 common shares held directly. Tornehl also has 959.278 common shares held indirectly through the company ESOP and continues to hold multiple tranches of performance stock units, with target amounts of 3,341, 3,833, and 4,350 units tied to multi-year performance goals based on EBITDA growth, revenue, and return on invested capital, each capable of paying out between 0% and 200% of target depending on results.
Sensient Technologies Corporation filed its annual report describing 2025 operations across three main segments: Flavors & Extracts, Color, and Asia Pacific, supported by a Corporate & Other category. The company positions itself as a leading global supplier of colors, flavors, and specialty ingredients to food, beverage, pharmaceutical, nutraceutical, and personal care customers.
In 2025 Sensient acquired Biolie SAS, a natural color extraction business in France, for $4.9 million in cash, allocating $4.6 million to goodwill within the Color segment. The company emphasizes its long-term investment in natural color capabilities as regulatory and customer trends accelerate the shift away from synthetic food colors.
The report details extensive risk factors, including macroeconomic volatility, tariffs and trade disputes, raw material and energy cost inflation, supply-chain disruptions, regulatory changes on synthetic colors and ultra-processed foods, ESG-related pressures, and cybersecurity threats. Sensient reports a global workforce of 4,070 employees as of December 31, 2025 and outlines comprehensive human capital, safety, food safety, and cybersecurity programs.
The company highlights use of non-GAAP measures such as adjusted operating income, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA to evaluate performance. As of June 30, 2025, the aggregate market value of voting common stock held by non‑affiliates was $4,117,864,471. There were 42,506,700 shares of common stock outstanding as of February 3, 2026.
Sensient has paid uninterrupted quarterly dividends since 1962. In 2025 it paid total cash dividends of $1.64 per share and most recently declared a $0.41 per share dividend payable on March 2, 2026 to shareholders of record on February 3, 2026. The company also discloses a share repurchase authorization from 2017 covering up to three million shares; 1,267,019 shares had been repurchased as of December 31, 2025, with 1,732,981 shares remaining authorized and no repurchases during 2025.
Sensient Technologies reported modest top-line growth for 2025 and issued upbeat 2026 guidance. Full-year revenue rose 3.5% while operating income increased 8.1%. GAAP diluted EPS grew 7.5% to $3.16 and adjusted diluted EPS rose 16.0% to $3.48, reflecting benefits from its Portfolio Optimization Plan.
Fourth-quarter results were mixed: revenue grew 4.5%, but operating income fell 9.1% and GAAP diluted EPS declined 15.5% to $0.60. Adjusted diluted EPS, however, improved 10.8% to $0.72. Color delivered double-digit revenue and operating income growth, while Flavors & Extracts faced lower volumes and a roughly $3 million one-time inventory charge tied to severe rains in California.
Cash flow from operations decreased to $127,826 from $157,151, largely due to working capital, while capital expenditures rose to $89,409 and total debt increased to $709.6 million, keeping net debt to credit adjusted EBITDA at 2.3x. For 2026, Sensient targets mid-single to double-digit local currency growth in revenue and adjusted EBITDA, GAAP EPS of $3.60–$3.80, and mid- to high single-digit growth in local currency adjusted EPS.
Sensient Technologies executive President, Flavors & Extracts, reported his initial ownership of the company’s stock. He directly holds 1,808.751 shares of common stock, including restricted shares under the 2017 Stock Plan and shares in a dividend reinvestment plan.
He also holds performance stock units that each represent a contingent right to receive one share of common stock. One award covers 1,864 target shares tied to revenue and return on invested capital over a performance period from January 1, 2026 through December 31, 2028. Another award covers 575 target shares granted under the 2017 Stock Plan, with a three-year performance period from January 1, 2025 through December 31, 2027, based 70% on EBITDA growth and 30% on return on invested capital. Actual shares earned can range from 0% to 150% of the target amounts, subject to performance and continued employment conditions.
Sensient Technologies Corp. director Form 4 shows a routine fee deferral into stock-based compensation. On 12/31/2025, the director elected to defer fees under the company’s Directors’ Deferred Compensation Plan, receiving 388.771 units of deferred stock that convert into common shares on a one-for-one basis.
After this transaction, the director beneficially owns 22,484.448 shares of common stock directly and 23,263.025 derivative securities classified as deferred stock. The filing explains that common shares from the deferred stock will be issued when the director’s board service ends, and current holdings also include restricted stock under the 2017 Stock Plan and shares held through a dividend reinvestment plan.
Sensient Technologies Corp. director Dr. Ferruzzi reported equity holdings and a new deferred stock award. On 12/31/2025, the director acquired 58.861 shares of deferred stock, which convert to common stock on a one-for-one basis under the company’s Directors’ Deferred Compensation Plan. Following the reported transactions, the director beneficially owns 8,043.478 shares of common stock directly and 227.421 shares indirectly through a spouse’s ESOP account. Some of the directly held shares are restricted stock under the 2017 Stock Plan and shares in a dividend reinvestment plan. The deferred stock will result in common shares being issued when the director’s service with the company ends.
Sensient Technologies Corp. director reports deferred stock transaction
A director of Sensient Technologies Corp. (SXT) reported a routine equity-related transaction. On 12/31/2025, the director acquired 102.821 shares of deferred stock through the deferral of director fees under the company’s Directors' Deferred Compensation Plan. This deferred stock is convertible into common stock on a one-for-one basis, with shares of common stock to be issued when the director’s board service ends.
Following this transaction, the director beneficially owned 16,394.007 shares of common stock directly and 5,702.328 derivative securities in the form of deferred stock. The filing identifies the reporting person as a director and indicates the ownership is held directly.
Sensient Technologies Corp reported that its Color Group president received new equity awards in the form of restricted stock and performance stock units. On December 17, 2025, he was granted 3,418 shares of common stock at a price of $0 under the company’s 2017 Stock Plan; these shares are restricted for three years following the grant date.
He also acquired 5,126 performance stock units, each representing a contingent right to one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028, based on revenue and return on invested capital. Following the reported transactions, he beneficially owns 42,758.541 shares directly, plus additional shares through a supplemental benefit plan and an ESOP.
The filing also lists earlier performance stock unit grants tied to three-year performance periods ending in 2025, 2026 and 2027. For those prior awards, the number of shares ultimately earned depends on achieving performance criteria based on EBITDA growth and return on invested capital, with potential payouts ranging from 0% to 200% of the target award amount.